This issue is much more likely to happen if you are taking a GLP-1 agonist, since they slow down the movement of food and liquid out of the stomach and into the intestine
CNC Accepts Medicare Bridge Wegovy, Zepbound, and Foundayo are covered at $50/month for eligible Medicare patients under the 2026 GLP-1 Bridge program through December 31, 2027
The expression of pro-inflammatory mediators, including interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF-), increase in cartilage, bone, and synovium, contributing to the initiation of OA 4,5
Click to read the study, published today in NEJM Relevant Reading: The Interleukin-17 Pathway in Psoriasis and Psoriatic Arthritis: Disease Pathogenesis and Possibilities of Treatment In-Depth [randomized controlled trial]: This study enrolled a total of 168 patients randomized 1:1:1 into the following groups: brodalumab 140mg, brodalumab 280mg and placebo
January 5, 2026: Dozens of Ozempic Vision Loss Lawsuits Now Grouped Together in Federal Court The new MDL for GLP-1 vision loss cases has now been established, with 29 cases placed before one judge